Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide

Isr Med Assoc J. 2005 Jun;7(6):408-9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Inhalation
  • Antihypertensive Agents / therapeutic use*
  • Endothelium-Dependent Relaxing Factors / therapeutic use
  • Epoprostenol / therapeutic use*
  • Humans
  • Infant, Newborn
  • Infusions, Intravenous
  • Male
  • Nitric Oxide / therapeutic use
  • Persistent Fetal Circulation Syndrome / drug therapy*

Substances

  • Antihypertensive Agents
  • Endothelium-Dependent Relaxing Factors
  • Nitric Oxide
  • Epoprostenol